McPherson, T. L., & Hersch, R. K. (2000). Brief substance use screening instruments for primary care
settings: A review. Journal of Substance Abuse Treatment, 18(2) 193-202.
McPherson, T. L., Goplerud, E., Derr, D., Mickenberg, J., & Courtemanche, S. (2010). Telephonic
screening and brief intervention for alcohol misuse among workers contacting the employee
assistance program: A feasibility study. Drug & Alcohol Review, 29(6), 641-646.
McPherson, T., Lusby-Treber, K., Goplerud , E., & Walsh, T. (2007). Alcohol screening and brief
intervention in the workplace: Opportunities for early identification and intervention. Washington,
DC: George Washington University Medical Center, Department of Health Policy, Ensuring
Solutions to Alcohol Problems.
McQueeny, T., Schweinsburg, B. C., Schweinsburg, A. D., Jacobus, J., Bava, S., Frank, L. R., et al.
(2009). Altered white matter integrity in adolescent binge drinkers. Alcoholism: Clinical &
Experimental Research, 33(7), 1278-1285.
Mead, H., Cartwright-Smith, L., Jones, K., Ramos, C., Siegel, B., & Woods, K. (2008). Racial and ethnic
disparities in U.S. health care: A chartbook. [Online]. Retrieved April 18, 2012 from
http://www.commonwealthfund.org.
Meader, N. (2010). A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for
opioid detoxification: A mixed treatment comparison meta-analysis. Drug & Alcohol Dependence,
108 (1-2), 110-114.
Meandzija, B., O'Connor, P. G., Fitzgerald, B., Rounsaville, B. J., & Kosten, T. R. (1994). HIV infection
and cocaine use in methadone maintained and untreated intravenous drug users. Drug & Alcohol
Dependence, 36(2), 109-113.
Meaney, M. J., Brake, W., & Gratton, A. (2002). Environmental regulation of the development of
mesolimbic dopamine systems: A neurobiological mechanism for vulnerability to drug abuse?
Psychoneuroendocrinology, 27(1-2), 127-138.
Mecklenburg, R. E. (2001). Tobacco prevention and control in dental practice: The future. Journal of
Dental Education, 65(4), 375-384.
Medicare Interactive. (2012). Medicare coverage of treatment for alcoholism and drug abuse. [Online].
Retrieved March 19, 2012 from http://www.medicareinteractive.org.
Medina, K. L., Schweinsburg, A. D., Cohen-Zion, M., Nagel, B. J., & Tapert, S. F. (2007). Effects of
alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and
asymmetry. Neurotoxicology & Teratology, 29(1), 141-152.
Mejta, C. L., Bokos, P. J., Mickenberg, J., Maslar, M. E., & Senary, E. (1997). Improving substance
abuse treatment access and retention using a case management approach. Journal of Drug Issues,
27 (2), 329-340.
Mercure, S., & Greenberg, L. (2009). eValue8 employer report: Health plan tobacco cessation
performance. [Online]. Retrieved May 15, 2012 from http://www.nbch.org.
Merikangas, K. R., & McClair, V. L. (2012). Epidemiology of substance use disorders. Human Genetics,
131 (6), 779-789.
Merikangas, K. R., Stolar, M., Stevens, D. E., Goulet, J., Preisig, M. A., Fenton, B., et al. (1998). Familial
transmission of substance use disorders. Archives of General Psychiatry, 55(11), 973-979.
Merlo, L. J., & Gold, M. (2008). Prescription opioid abuse and dependence among physicians:
Hypotheses and treatment. Harvard Review of Psychiatry, 16(3), 181-194.